Sep 26, 2013
Of the 1.03 trillion RMB spent on R&D in China in 2012 (+18.5 compared to 2011), Jiangsu, Guangdong, Beijing, Shandong, Zhejiang and Shanghai spent 600.98 billion yuan, accounting for 58.4% of the total national funds. Basic research contributed 49.88 billion...
Sep 26, 2013
The Thailand-based company operates a 2000 m2 production plant is produces growth factors and humanized therapeutic antibodies based on mammalian cell culture. Expected sales in 2013 are 400 million RMB. China Bio news release, Sept. 26, 2013
Sep 26, 2013
According to statistics of the Ministry of Health, there are 900.000 cases of birth defects among the 16 million births in China. The test is based on the blood of pregnant women and considered a step in pregnancy eugenics. Bio China news, Sept. 26, 2013
Sep 26, 2013
The company will be located in Hangzhou, Zhejiang Province. Among the products for joint development and marketing are Vectibix, a humanized EGFR antibody for the treatment of colorectal cancer but requiring genetic subgroup analysis China Bio press release, Sept. 26,...
Sep 26, 2013
With investments of nearly 70 million €, production capacity will expand 3-fold by 2018, with up to 350 employees. China Bio news release, Sept. 26, 2013
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
